Global Intravenous Immunoglobulin (IVIg) Market Growth 2020-2025
According to this study, over the next five years the Intravenous Immunoglobulin (IVIg) market will register a 6.1% CAGR in terms of revenue, the global market size will reach $ 11350 million by 2025, from $ 8953.1 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Intravenous Immunoglobulin (IVIg) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Immunoglobulin (IVIg) market by type, application, key manufacturers and key regions and countries.
This study considers the Intravenous Immunoglobulin (IVIg) value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
IVIg Liquid
IVIg Powder
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Immunodeficiency
Autoimmune Disease
Acute Infection
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Baxter
CBPO
Grifols
Octapharma
Biotest
CSL
CNBG
Kedrion
Shanghai RAAS
Hualan Bio
LFB Group
Sichuan Yuanda Shuyang
BPL
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Intravenous Immunoglobulin (IVIg) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Intravenous Immunoglobulin (IVIg) market by identifying its various subsegments.
Focuses on the key global Intravenous Immunoglobulin (IVIg) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Intravenous Immunoglobulin (IVIg) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Intravenous Immunoglobulin (IVIg) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intravenous Immunoglobulin (IVIg) Consumption 2015-2025
2.1.2 Intravenous Immunoglobulin (IVIg) Consumption CAGR by Region
2.2 Intravenous Immunoglobulin (IVIg) Segment by Type
2.2.1 IVIg Liquid
2.2.2 IVIg Powder
2.3 Intravenous Immunoglobulin (IVIg) Consumption by Type
2.3.1 Global Intravenous Immunoglobulin (IVIg) Consumption Market Share by Type (2015-2020)
2.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2015-2020)
2.3.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Type (2015-2020)
2.4 Intravenous Immunoglobulin (IVIg) Segment by Application
2.4.1 Immunodeficiency
2.4.2 Autoimmune Disease
2.4.3 Acute Infection
2.5 Intravenous Immunoglobulin (IVIg) Consumption by Application
2.5.1 Global Intravenous Immunoglobulin (IVIg) Consumption Market Share by Type (2015-2020)
2.5.2 Global Intravenous Immunoglobulin (IVIg) Value and Market Share by Type (2015-2020)
2.5.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Type (2015-2020)
3 Global Intravenous Immunoglobulin (IVIg) by Company
3.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company
3.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Company (2018-2020)
3.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2018-2020)
3.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company
3.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Company (2018-2020)
3.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2018-2020)
3.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Company
3.4 Global Intravenous Immunoglobulin (IVIg) Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Intravenous Immunoglobulin (IVIg) Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Intravenous Immunoglobulin (IVIg) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Intravenous Immunoglobulin (IVIg) by Regions
4.1 Intravenous Immunoglobulin (IVIg) by Regions
4.2 Americas Intravenous Immunoglobulin (IVIg) Consumption Growth
4.3 APAC Intravenous Immunoglobulin (IVIg) Consumption Growth
4.4 Europe Intravenous Immunoglobulin (IVIg) Consumption Growth
4.5 Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Growth
5 Americas
5.1 Americas Intravenous Immunoglobulin (IVIg) Consumption by Countries
5.1.1 Americas Intravenous Immunoglobulin (IVIg) Consumption by Countries (2015-2020)
5.1.2 Americas Intravenous Immunoglobulin (IVIg) Value by Countries (2015-2020)
5.2 Americas Intravenous Immunoglobulin (IVIg) Consumption by Type
5.3 Americas Intravenous Immunoglobulin (IVIg) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Intravenous Immunoglobulin (IVIg) Consumption by Regions
6.1.1 APAC Intravenous Immunoglobulin (IVIg) Consumption by Regions (2015-2020)
6.1.2 APAC Intravenous Immunoglobulin (IVIg) Value by Regions (2015-2020)
6.2 APAC Intravenous Immunoglobulin (IVIg) Consumption by Type
6.3 APAC Intravenous Immunoglobulin (IVIg) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Intravenous Immunoglobulin (IVIg) by Countries
7.1.1 Europe Intravenous Immunoglobulin (IVIg) Consumption by Countries (2015-2020)
7.1.2 Europe Intravenous Immunoglobulin (IVIg) Value by Countries (2015-2020)
7.2 Europe Intravenous Immunoglobulin (IVIg) Consumption by Type
7.3 Europe Intravenous Immunoglobulin (IVIg) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) by Countries
8.1.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Value by Countries (2015-2020)
8.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption by Type
8.3 Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Intravenous Immunoglobulin (IVIg) Distributors
10.3 Intravenous Immunoglobulin (IVIg) Customer
11 Global Intravenous Immunoglobulin (IVIg) Market Forecast
11.1 Global Intravenous Immunoglobulin (IVIg) Consumption Forecast (2021-2025)
11.2 Global Intravenous Immunoglobulin (IVIg) Forecast by Regions
11.2.1 Global Intravenous Immunoglobulin (IVIg) Forecast by Regions (2021-2025)
11.2.2 Global Intravenous Immunoglobulin (IVIg) Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Intravenous Immunoglobulin (IVIg) Forecast by Type
11.8 Global Intravenous Immunoglobulin (IVIg) Forecast by Application
12 Key Players Analysis
12.1 Baxter
12.1.1 Company Information
12.1.2 Intravenous Immunoglobulin (IVIg) Product Offered
12.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Baxter Latest Developments
12.2 CBPO
12.2.1 Company Information
12.2.2 Intravenous Immunoglobulin (IVIg) Product Offered
12.2.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 CBPO Latest Developments
12.3 Grifols
12.3.1 Company Information
12.3.2 Intravenous Immunoglobulin (IVIg) Product Offered
12.3.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Grifols Latest Developments
12.4 Octapharma
12.4.1 Company Information
12.4.2 Intravenous Immunoglobulin (IVIg) Product Offered
12.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Octapharma Latest Developments
12.5 Biotest
12.5.1 Company Information
12.5.2 Intravenous Immunoglobulin (IVIg) Product Offered
12.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Biotest Latest Developments
12.6 CSL
12.6.1 Company Information
12.6.2 Intravenous Immunoglobulin (IVIg) Product Offered
12.6.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 CSL Latest Developments
12.7 CNBG
12.7.1 Company Information
12.7.2 Intravenous Immunoglobulin (IVIg) Product Offered
12.7.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 CNBG Latest Developments
12.8 Kedrion
12.8.1 Company Information
12.8.2 Intravenous Immunoglobulin (IVIg) Product Offered
12.8.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Kedrion Latest Developments
12.9 Shanghai RAAS
12.9.1 Company Information
12.9.2 Intravenous Immunoglobulin (IVIg) Product Offered
12.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Shanghai RAAS Latest Developments
12.10 Hualan Bio
12.10.1 Company Information
12.10.2 Intravenous Immunoglobulin (IVIg) Product Offered
12.10.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Hualan Bio Latest Developments
12.11 LFB Group
12.11.1 Company Information
12.11.2 Intravenous Immunoglobulin (IVIg) Product Offered
12.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 LFB Group Latest Developments
12.12 Sichuan Yuanda Shuyang
12.12.1 Company Information
12.12.2 Intravenous Immunoglobulin (IVIg) Product Offered
12.12.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Sichuan Yuanda Shuyang Latest Developments
12.13 BPL
12.13.1 Company Information
12.13.2 Intravenous Immunoglobulin (IVIg) Product Offered
12.13.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 BPL Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Intravenous Immunoglobulin (IVIg) Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of IVIg Liquid
Table 5. Major Players of IVIg Powder
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Intravenous Immunoglobulin (IVIg) Consumption Market Share by Type (2015-2020)
Table 8. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2015-2020) ($ million)
Table 9. Global Intravenous Immunoglobulin (IVIg) Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Intravenous Immunoglobulin (IVIg) Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Intravenous Immunoglobulin (IVIg) Consumption Market Share by Application (2015-2020)
Table 13. Global Intravenous Immunoglobulin (IVIg) Value by Application (2015-2020)
Table 14. Global Intravenous Immunoglobulin (IVIg) Value Market Share by Application (2015-2020)
Table 15. Global Intravenous Immunoglobulin (IVIg) Sale Price by Application (2015-2020)
Table 16. Global Intravenous Immunoglobulin (IVIg) Sales by Company (2017-2019) (K Bottle)
Table 17. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2017-2019)
Table 18. Global Intravenous Immunoglobulin (IVIg) Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2017-2019)
Table 20. Global Intravenous Immunoglobulin (IVIg) Sale Price by Company (2017-2019)
Table 21. Global Intravenous Immunoglobulin (IVIg) Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Intravenous Immunoglobulin (IVIg) Products Offered
Table 23. Intravenous Immunoglobulin (IVIg) Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Intravenous Immunoglobulin (IVIg) Consumption by Regions 2015-2020 (K Bottle)
Table 25. Global Intravenous Immunoglobulin (IVIg) Consumption Market Share by Regions 2015-2020
Table 26. Global Intravenous Immunoglobulin (IVIg) Value by Regions 2015-2020 ($ Millions)
Table 27. Global Intravenous Immunoglobulin (IVIg) Value Market Share by Regions 2015-2020
Table 28. Americas Intravenous Immunoglobulin (IVIg) Consumption by Countries (2015-2020) (K Bottle)
Table 29. Americas Intravenous Immunoglobulin (IVIg) Consumption Market Share by Countries (2015-2020)
Table 30. Americas Intravenous Immunoglobulin (IVIg) Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Intravenous Immunoglobulin (IVIg) Value Market Share by Countries (2015-2020)
Table 32. Americas Intravenous Immunoglobulin (IVIg) Consumption by Type (2015-2020) (K Bottle)
Table 33. Americas Intravenous Immunoglobulin (IVIg) Consumption Market Share by Type (2015-2020)
Table 34. Americas Intravenous Immunoglobulin (IVIg) Consumption by Application (2015-2020) (K Bottle)
Table 35. Americas Intravenous Immunoglobulin (IVIg) Consumption Market Share by Application (2015-2020)
Table 36. APAC Intravenous Immunoglobulin (IVIg) Consumption by Countries (2015-2020) (K Bottle)
Table 37. APAC Intravenous Immunoglobulin (IVIg) Consumption Market Share by Countries (2015-2020)
Table 38. APAC Intravenous Immunoglobulin (IVIg) Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Intravenous Immunoglobulin (IVIg) Value Market Share by Regions (2015-2020)
Table 40. APAC Intravenous Immunoglobulin (IVIg) Consumption by Type (2015-2020) (K Bottle)
Table 41. APAC Intravenous Immunoglobulin (IVIg) Consumption Market Share by Type (2015-2020)
Table 42. APAC Intravenous Immunoglobulin (IVIg) Consumption by Application (2015-2020) (K Bottle)
Table 43. APAC Intravenous Immunoglobulin (IVIg) Consumption Market Share by Application (2015-2020)
Table 44. Europe Intravenous Immunoglobulin (IVIg) Consumption by Countries (2015-2020) (K Bottle)
Table 45. Europe Intravenous Immunoglobulin (IVIg) Consumption Market Share by Countries (2015-2020)
Table 46. Europe Intravenous Immunoglobulin (IVIg) Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Intravenous Immunoglobulin (IVIg) Value Market Share by Countries (2015-2020)
Table 48. Europe Intravenous Immunoglobulin (IVIg) Consumption by Type (2015-2020) (K Bottle)
Table 49. Europe Intravenous Immunoglobulin (IVIg) Consumption Market Share by Type (2015-2020)
Table 50. Europe Intravenous Immunoglobulin (IVIg) Consumption by Application (2015-2020) (K Bottle)
Table 51. Europe Intravenous Immunoglobulin (IVIg) Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption by Countries (2015-2020) (K Bottle)
Table 53. Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Intravenous Immunoglobulin (IVIg) Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Intravenous Immunoglobulin (IVIg) Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption by Type (2015-2020) (K Bottle)
Table 57. Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption by Application (2015-2020) (K Bottle)
Table 59. Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Market Share by Application (2015-2020)
Table 60. Intravenous Immunoglobulin (IVIg) Distributors List
Table 61. Intravenous Immunoglobulin (IVIg) Customer List
Table 62. Global Intravenous Immunoglobulin (IVIg) Consumption Forecast by Countries (2021-2025) (K Bottle)
Table 63. Global Intravenous Immunoglobulin (IVIg) Consumption Market Forecast by Regions
Table 64. Global Intravenous Immunoglobulin (IVIg) Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Intravenous Immunoglobulin (IVIg) Value Market Share Forecast by Regions
Table 66. Global Intravenous Immunoglobulin (IVIg) Consumption Forecast by Type (2021-2025) (K Bottle)
Table 67. Global Intravenous Immunoglobulin (IVIg) Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Intravenous Immunoglobulin (IVIg) Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Intravenous Immunoglobulin (IVIg) Value Market Share Forecast by Type (2021-2025)
Table 70. Global Intravenous Immunoglobulin (IVIg) Consumption Forecast by Application (2021-2025) (K Bottle)
Table 71. Global Intravenous Immunoglobulin (IVIg) Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Intravenous Immunoglobulin (IVIg) Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Intravenous Immunoglobulin (IVIg) Value Market Share Forecast by Application (2021-2025)
Table 74. Baxter Product Offered
Table 75. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2018-2020E)
Table 76. Baxter Main Business
Table 77. Baxter Latest Developments
Table 78. Baxter Basic Information, Company Total Revenue (in $ million), Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 79. CBPO Product Offered
Table 80. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2018-2020E)
Table 81. CBPO Main Business
Table 82. CBPO Latest Developments
Table 83. CBPO Basic Information, Company Total Revenue (in $ million), Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 84. Grifols Product Offered
Table 85. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2018-2020E)
Table 86. Grifols Main Business
Table 87. Grifols Latest Developments
Table 88. Grifols Basic Information, Company Total Revenue (in $ million), Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 89. Octapharma Product Offered
Table 90. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2018-2020E)
Table 91. Octapharma Main Business
Table 92. Octapharma Latest Developments
Table 93. Octapharma Basic Information, Company Total Revenue (in $ million), Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 94. Biotest Product Offered
Table 95. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2018-2020E)
Table 96. Biotest Main Business
Table 97. Biotest Latest Developments
Table 98. Biotest Basic Information, Company Total Revenue (in $ million), Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 99. CSL Product Offered
Table 100. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2018-2020E)
Table 101. CSL Main Business
Table 102. CSL Latest Developments
Table 103. CSL Basic Information, Company Total Revenue (in $ million), Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 104. CNBG Product Offered
Table 105. CNBG Basic Information, Company Total Revenue (in $ million), Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 106. CNBG Main Business
Table 107. CNBG Latest Developments
Table 108. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2018-2020E)
Table 109. Kedrion Product Offered
Table 110. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2018-2020E)
Table 111. Kedrion Main Business
Table 112. Kedrion Latest Developments
Table 113. Kedrion Basic Information, Company Total Revenue (in $ million), Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 114. Shanghai RAAS Product Offered
Table 115. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2018-2020E)
Table 116. Shanghai RAAS Main Business
Table 117. Shanghai RAAS Latest Developments
Table 118. Shanghai RAAS Basic Information, Company Total Revenue (in $ million), Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 119. Hualan Bio Product Offered
Table 120. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2018-2020E)
Table 121. Hualan Bio Main Business
Table 122. Hualan Bio Latest Developments
Table 123. Hualan Bio Basic Information, Company Total Revenue (in $ million), Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 124. LFB Group Product Offered
Table 125. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2018-2020E)
Table 126. LFB Group Main Business
Table 127. LFB Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. LFB Group Latest Developments
Table 129. Sichuan Yuanda Shuyang Product Offered
Table 130. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2018-2020E)
Table 131. Sichuan Yuanda Shuyang Main Business
Table 132. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Sichuan Yuanda Shuyang Latest Developments
Table 134. BPL Product Offered
Table 135. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2018-2020E)
Table 136. BPL Main Business
Table 137. BPL Latest Developments
Table 138. BPL Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Intravenous Immunoglobulin (IVIg)
Figure 2. Intravenous Immunoglobulin (IVIg) Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Intravenous Immunoglobulin (IVIg) Consumption Growth Rate 2015-2025 (K Bottle)
Figure 5. Global Intravenous Immunoglobulin (IVIg) Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of IVIg Liquid
Figure 7. Product Picture of IVIg Powder
Figure 8. Global Intravenous Immunoglobulin (IVIg) Consumption Market Share by Type (2015-2020)
Figure 9. Global Intravenous Immunoglobulin (IVIg) Value Market Share by Type (2015-2020)
Figure 10. Intravenous Immunoglobulin (IVIg) Consumed in Immunodeficiency
Figure 11. Global Intravenous Immunoglobulin (IVIg) Market: Immunodeficiency (2015-2020) (K Bottle)
Figure 12. Global Intravenous Immunoglobulin (IVIg) Market: Immunodeficiency (2015-2020) ($ Millions)
Figure 13. Intravenous Immunoglobulin (IVIg) Consumed in Autoimmune Disease
Figure 14. Global Intravenous Immunoglobulin (IVIg) Market: Autoimmune Disease (2015-2020) (K Bottle)
Figure 15. Global Intravenous Immunoglobulin (IVIg) Market: Autoimmune Disease (2015-2020) ($ Millions)
Figure 16. Intravenous Immunoglobulin (IVIg) Consumed in Acute Infection
Figure 17. Global Intravenous Immunoglobulin (IVIg) Market: Acute Infection (2015-2020) (K Bottle)
Figure 18. Global Intravenous Immunoglobulin (IVIg) Market: Acute Infection (2015-2020) ($ Millions)
Figure 19. Global Intravenous Immunoglobulin (IVIg) Consumption Market Share by Application (2015-2020)
Figure 20. Global Intravenous Immunoglobulin (IVIg) Value Market Share by Application (2015-2020)
Figure 21. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company in 2017
Figure 22. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company in 2019
Figure 23. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company in 2017
Figure 24. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company in 2019
Figure 25. Global Intravenous Immunoglobulin (IVIg) Sale Price by Company in 2019
Figure 26. Global Intravenous Immunoglobulin (IVIg) Consumption Market Share by Regions 2015-2020
Figure 27. Global Intravenous Immunoglobulin (IVIg) Value Market Share by Regions 2015-2020
Figure 28. Americas Intravenous Immunoglobulin (IVIg) Consumption 2015-2020 (K Bottle)
Figure 29. Americas Intravenous Immunoglobulin (IVIg) Value 2015-2020 ($ Millions)
Figure 30. APAC Intravenous Immunoglobulin (IVIg) Consumption 2015-2020 (K Bottle)
Figure 31. APAC Intravenous Immunoglobulin (IVIg) Value 2015-2020 ($ Millions)
Figure 32. Europe Intravenous Immunoglobulin (IVIg) Consumption 2015-2020 (K Bottle)
Figure 33. Europe Intravenous Immunoglobulin (IVIg) Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption 2015-2020 (K Bottle)
Figure 35. Middle East & Africa Intravenous Immunoglobulin (IVIg) Value 2015-2020 ($ Millions)
Figure 36. Americas Intravenous Immunoglobulin (IVIg) Consumption Market Share by Countries in 2019
Figure 37. Americas Intravenous Immunoglobulin (IVIg) Value Market Share by Countries in 2019
Figure 38. Americas Intravenous Immunoglobulin (IVIg) Consumption Market Share by Type in 2019
Figure 39. Americas Intravenous Immunoglobulin (IVIg) Consumption Market Share by Application in 2019
Figure 40. United States Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 41. United States Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 43. Canada Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 45. Mexico Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Intravenous Immunoglobulin (IVIg) Consumption Market Share by Countries in 2019
Figure 47. APAC Intravenous Immunoglobulin (IVIg) Value Market Share by Regions in 2019
Figure 48. APAC Intravenous Immunoglobulin (IVIg) Consumption Market Share by Type in 2019
Figure 49. APAC Intravenous Immunoglobulin (IVIg) Consumption Market Share by Application in 2019
Figure 50. China Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 51. China Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 53. Japan Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 55. Korea Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 57. Southeast Asia Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 58. India Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 59. India Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 61. Australia Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Intravenous Immunoglobulin (IVIg) Consumption Market Share by Countries in 2019
Figure 63. Europe Intravenous Immunoglobulin (IVIg) Value Market Share by Countries in 2019
Figure 64. Europe Intravenous Immunoglobulin (IVIg) Consumption Market Share by Type in 2019
Figure 65. Europe Intravenous Immunoglobulin (IVIg) Consumption Market Share by Application in 2019
Figure 66. Germany Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 67. Germany Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 68. France Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 69. France Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 70. UK Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 71. UK Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 73. Italy Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 75. Russia Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 76. Spain Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 77. Spain Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Intravenous Immunoglobulin (IVIg) Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Market Share by Application in 2019
Figure 82. Egypt Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 83. Egypt Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 85. South Africa Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 87. Israel Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 89. Turkey Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Intravenous Immunoglobulin (IVIg) Consumption Growth 2015-2020 (K Bottle)
Figure 91. GCC Countries Intravenous Immunoglobulin (IVIg) Value Growth 2015-2020 ($ Millions)
Figure 92. Global Intravenous Immunoglobulin (IVIg) Consumption Growth Rate Forecast (2021-2025) (K Bottle)
Figure 93. Global Intravenous Immunoglobulin (IVIg) Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 95. Americas Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 96. APAC Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 97. APAC Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 98. Europe Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 99. Europe Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 101. Middle East & Africa Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 102. United States Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 103. United States Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 104. Canada Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 105. Canada Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 106. Mexico Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 107. Mexico Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 108. Brazil Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 109. Brazil Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 110. China Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 111. China Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 112. Japan Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 113. Japan Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 114. Korea Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 115. Korea Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 117. Southeast Asia Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 118. India Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 119. India Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 120. Australia Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 121. Australia Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 122. Germany Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 123. Germany Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 124. France Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 125. France Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 126. UK Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 127. UK Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 128. Italy Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 129. Italy Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 130. Russia Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 131. Russia Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 132. Spain Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 133. Spain Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 134. Egypt Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 135. Egypt Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 136. South Africa Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 137. South Africa Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 138. Israel Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 139. Israel Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 140. Turkey Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 141. Turkey Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Intravenous Immunoglobulin (IVIg) Consumption 2021-2025 (K Bottle)
Figure 143. GCC Countries Intravenous Immunoglobulin (IVIg) Value 2021-2025 ($ Millions)
Figure 144. Baxter Intravenous Immunoglobulin (IVIg) Market Share (2018-2020)
Figure 145. CBPO Intravenous Immunoglobulin (IVIg) Market Share (2018-2020)
Figure 146. Grifols Intravenous Immunoglobulin (IVIg) Market Share (2018-2020)
Figure 147. Octapharma Intravenous Immunoglobulin (IVIg) Market Share (2018-2020)
Figure 148. Biotest Intravenous Immunoglobulin (IVIg) Market Share (2018-2020)
Figure 149. CSL Intravenous Immunoglobulin (IVIg) Market Share (2018-2020)
Figure 150. CNBG Intravenous Immunoglobulin (IVIg) Market Share (2018-2020)
Figure 151. Kedrion Intravenous Immunoglobulin (IVIg) Market Share (2018-2020)
Figure 152. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Market Share (2018-2020)
Figure 153. Hualan Bio Intravenous Immunoglobulin (IVIg) Market Share (2018-2020)
Figure 154. LFB Group Intravenous Immunoglobulin (IVIg) Market Share (2018-2020)
Figure 155. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Market Share (2018-2020)
Figure 156. BPL Intravenous Immunoglobulin (IVIg) Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets